Avelumab-Induced Scleroderma in a Patient with Metastatic Squamous Cell Carcinoma of the Lung

• Hauptverfasser: Jeffrey L. Dobrzynski (Verfasst von), Blake E. Vest (Verfasst von), Brian L. Swick (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2022-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Immune checkpoint inhibitors are associated with a spectrum of cutaneous immune-related adverse events. While maculopapular eruptions are the most common cutaneous adverse event, scleroderma can rarely develop. Herein, we report a case of new-onset scleroderma associated with avelumab treatment in t...